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A B S T R A C T
An 84-year-old lady, admitted with acute inferior wall myocardial infarction (STEMI), 
was subjected to emergent coronary angiography and percutaneous coronary interven-
tion (PCI) of a totally occluded right coronary artery (RCA). When the occlusion was 
crossed with an angioplasty wire and dilated with a small balloon, it became apparent 
that the artery had markedly reduced flow as it was filled with thrombi, which were 
successfully removed with use of a thromboaspiration catheter. Thromboaspiration, 
subsequent stenting and a IIB/IIIA antiplatlet agent led to full mechanical recanaliza-
tion and complete restoration of TIMI 3 blood flow to the artery. This interventional 
strategy prevented distal embolization of the intracoronary thrombi and thus the no-
reflow phenomenon, which would have otherwise developed in this complex PCI case 
with such a heavy thrombotic load.
C A S E
An 84-year-old lady, ex-smoker, hypertensive and hypercholesterolemic, was admitted 
via the emergency room with complaints of chest pain, recurring over the preceding 2 
days. She was found to have ECG changes of a recent ST-elevation acute inferior wall 
myocardial infarction (STEMI). She was subjected to emergent coronary angiography, 
which revealed a total occlusion of the right coronary artery (RCA) (Panel A). During 
the same session, percutaneous coronary intervention (PCI) was attempted. The occlu-
sion was successfully crossed with an angioplasty wire and dilation with a small balloon 
restored partial blood flow, when it became apparent that the artery was filled with 
clots (intraluminal defects) (Panel B). At this point a 6F thromboaspiration catheter 
(Export AP aspiration catheter, Medtronic, Minneapolis, Minnesota), was employed 
and an impressive amount of thrombotic material was aspirated (Panel C).
The combination of thromboaspiration, subsequent stenting and use of a IIB/IIIA 
antiplatlet agent (tirofiban) led to full mechanical recanalization and complete res-
toration of TIMI 3 blood flow to the artery (Panel D). This interventional strategy 
prevented distal embolization of the intraluminal thrombi and thus aborted the no-
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reflow phenomenon, which would have otherwise developed 
in this complex PCI case with such a heavy thrombotic load.
D I S C U S S I O N
Thromboaspiration or thrombectomy in patients with 
STEMI undergoing mechanical reperfusion via PCI has 
been shown not only to be associated with better myocardial 
reperfusion and obviation of the no-reflow phenomenon, but 
also to reduce infarct size and significantly improve the clinical 
outcome of these patients and its effect may be additional to 
that of IIb/IIIa-platelet inhibitors.1-7
In the TAPAS trial, among 1060 patients the benefit of 
thromboaspiration extended out to one year.6 Cardiac death at 
1 year was 3.6% in the thrombus aspiration group and 6.7% in 
the conventional PCI group (hazard ratio [HR] 1.93; p=0.020). 
One-year cardiac death or non-fatal reinfarction occurred in 
5.6% of patients in the thrombus aspiration group and 9.9% 
of patients in the conventional PCI group (HR 1.81; p=0.009). 
In a more recent, single-center study (EXPIRA), among 175 
patients with STEMI, manual thromboaspiration prevented 
thrombus embolization and preserved microvascular integrity 
reducing infarct size, as assessed by contrast-enhanced mag-
netic resonance imaging.4
Finally, a metaanalysis of 9 trials of thromboaspiration 
with different devices, demonstrated that, among 2417 patients 
with STEMI undergoing primary PCI, thromboaspiration was 
associated with better myocardial perfusion and less distal 
embolization, leading to significant improvement in 30-day 
survival.7 More recently, an individual patient-data pooled 
analysis of 11 trials showed that among 2686 STEMI patients 
with a median follow-up of one year, thromboaspiration led 
to significantly lower all-cause mortality (P = 0.049), fewer 
major adverse cardiac events (MACE) (P = 0.011) and lower 
death plus myocardial infarction rate during the follow-up (P 
= 0.015).2 Subgroup analysis showed that thromboaspiration 
was associated with improved survival in patients treated with 
IIb/IIIa-inhibitors (P = 0.045) and that the survival benefit 
was confined to patients treated in manual thrombectomy 
trials (P = 0.011).
Based on all this evidence, one can recommend that manual 
thromboaspiration, if anatomically and technically feasible, 
should be routinely added to our therapeutic armamentarium 
in STEMI patients undergoing primary PCI, as an adjunct to 
mechanical reperfusion and to the use of IIb/IIIa-inhibitors, as 
this simple therapeutic modality further improves late clinical 
outcome. It seems imperative that this recommendation should 
be incorporated in future clinical guidelines.
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